NCT00127920View on ClinicalTrials.gov

Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

October 31, 2012

Conditions

Ovarian Neoplasms

Interventions

DRUG

Avastin

Paclitaxel, Carboplatin and Avastin given on day 1 every 21 days

Trial Locations (2)

32803

Florida Hospital College of Health Sciences, Orlando

92663

Gynecologic Oncology Associates, Newport Beach

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Gynecologic Oncology Associates

OTHER